Desensitization of the beta-adrenoceptor-adenylate cyclase system of immature erythrocytes by in-vivo treatment of rats with isoprenaline.
D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone / Q000494:pharmacology; D000262:Adenylyl Cyclases / Q000097:blood*; D000318:Adrenergic beta-Agonists / Q000097:blood; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D004082:Dihydroalprenolol / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000378:metabolism*; D007545:Isoproterenol / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology*; D008297:Male; D010208:Papaverine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011941:Receptors, Adrenergic / Q000378:metabolism*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000378:metabolism*
D000318:Adrenergic beta-Agonists; D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D012368:4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; D004082:Dihydroalprenolol; C015272:hydroxybenzylisoproterenol; D010208:Papaverine; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D007545:Isoproterenol